332 related articles for article (PubMed ID: 6357121)
1. Heterologous immunity in rodent malaria: comparison of the degree of cross-immunity generated by vaccination with that produced by exposure to live infection.
McColm AA; Dalton L
Ann Trop Med Parasitol; 1983 Aug; 77(4):355-77. PubMed ID: 6357121
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and P. yoelii yoelii.
Jarra W; Brown KN
Parasite Immunol; 1989 Jan; 11(1):1-13. PubMed ID: 2648258
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter- and intra-species specificity of immunity induced by infection.
Jarra W; Brown KN
Parasite Immunol; 1985 Nov; 7(6):595-606. PubMed ID: 3912704
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
5. Protective immunity to malaria. Studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum.
Jarra W; Hills LA; March JC; Brown KN
Parasite Immunol; 1986 May; 8(3):239-54. PubMed ID: 3523398
[TBL] [Abstract][Full Text] [Related]
6. The Consequences of Mixed-Species Malaria Parasite Co-Infections in Mice and Mosquitoes for Disease Severity, Parasite Fitness, and Transmission Success.
Tang J; Templeton TJ; Cao J; Culleton R
Front Immunol; 2019; 10():3072. PubMed ID: 32038623
[TBL] [Abstract][Full Text] [Related]
7. Immunological studies in rodent malaria. I: Protective immunity induced in mice by mild strains of Plasmodium berghei yoelii against a virulent and fatal line of this plasmodium.
Hargreaves J; Yoeli M; Nussenzweig RS
Ann Trop Med Parasitol; 1975 Sep; 69(3):289-99. PubMed ID: 1098589
[TBL] [Abstract][Full Text] [Related]
8. Dynamics and Outcomes of
Conteh S; Kolasny J; Robbins YL; Pyana P; Büscher P; Musgrove J; Butler B; Lambert L; Gorres JP; Duffy PE
Am J Trop Med Hyg; 2020 Nov; 103(5):1893-1901. PubMed ID: 32815499
[TBL] [Abstract][Full Text] [Related]
9. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium berghei: long lasting immunity induced by a permanent attenuated mutant.
Miyagami T; Igarshi I; Suzuki M
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 May; 264(3-4):502-12. PubMed ID: 3310467
[TBL] [Abstract][Full Text] [Related]
11. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.
Wang T; Fujioka H; Drazba JA; Sam-Yellowe TY
Parasitol Res; 2006 Aug; 99(3):238-52. PubMed ID: 16541261
[TBL] [Abstract][Full Text] [Related]
12. Inability of Plasmodium vinckei-immune spleen cells to transfer protection to recipient mice exposed to vaccine 'vectors' or heterologous species of plasmodium.
Winkel KD; Good MF
Parasite Immunol; 1991 Sep; 13(5):517-30. PubMed ID: 1683480
[TBL] [Abstract][Full Text] [Related]
13. Antibody-independent immunity to reinfection malaria in B-cell-deficient mice.
Grun JL; Weidanz WP
Infect Immun; 1983 Sep; 41(3):1197-204. PubMed ID: 6350181
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms in immunity to blood stage infection.
Kumar S; Miller LH
Immunol Lett; 1990 Aug; 25(1-3):109-14. PubMed ID: 1980907
[TBL] [Abstract][Full Text] [Related]
15. Host defenses in murine malaria: immunological characteristics of a protracted state of immunity to Plasmodium yoelii.
Murphy JR
Infect Immun; 1980 Jan; 27(1):68-74. PubMed ID: 6987179
[TBL] [Abstract][Full Text] [Related]
16. Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei.
Playfair JH; De Souza JB; Cottrell BJ
Immunology; 1977 Oct; 33(4):507-15. PubMed ID: 336522
[TBL] [Abstract][Full Text] [Related]
17. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
Aly AS; Downie MJ; Mamoun CB; Kappe SH
Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
[TBL] [Abstract][Full Text] [Related]
18. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.
Purcell LA; Wong KA; Yanow SK; Lee M; Spithill TW; Rodriguez A
Vaccine; 2008 Sep; 26(38):4880-4. PubMed ID: 18672017
[TBL] [Abstract][Full Text] [Related]
19. Host defenses in murine malaria: analysis of the mechanisms of immunity to Plasmodium berghei generated in response to immunization with formalin-killed blood-stage parasites.
Murphy JR
Infect Immun; 1979 Jun; 24(3):707-12. PubMed ID: 381198
[TBL] [Abstract][Full Text] [Related]
20. Serological cross-reaction between rodent malaria parasites as determined by the indirect immunofluorescent technique.
el-Nahal HM
Bull World Health Organ; 1967; 36(3):423-9. PubMed ID: 4864305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
